Transcat, Inc. (NASDAQ:TRNS) Director Buys $92,424.00 in Stock

Transcat, Inc. (NASDAQ:TRNS) Director Craig D. Cairns bought 1,200 shares of the company’s stock in a transaction that occurred on Friday, January 31st. The shares were purchased at an average cost of $77.02 per share, for a total transaction of $92,424.00. Following the acquisition, the director now owns 1,910 shares of the company’s stock, valued at $147,108.20. This represents a 169.01 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website.

Transcat Stock Performance

TRNS traded up $0.20 during trading on Monday, reaching $77.22. The company had a trading volume of 108,401 shares, compared to its average volume of 116,733. The firm’s 50-day simple moving average is $103.15 and its 200 day simple moving average is $113.80. The company has a market cap of $710.42 million, a price-to-earnings ratio of 41.74 and a beta of 0.68. Transcat, Inc. has a 12-month low of $73.37 and a 12-month high of $147.12.

Transcat (NASDAQ:TRNS) last released its earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.43%. During the same period in the prior year, the company earned $0.56 EPS. On average, sell-side analysts expect that Transcat, Inc. will post 2.3 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Craig Hallum lifted their price target on Transcat from $113.00 to $125.00 and gave the company a “buy” rating in a research report on Thursday, December 12th. HC Wainwright dropped their price target on shares of Transcat from $126.00 to $106.00 and set a “buy” rating on the stock in a research report on Wednesday, January 29th. Northland Securities reissued a “market perform” rating and issued a $85.00 price target (down from $110.00) on shares of Transcat in a report on Wednesday, January 29th. Oppenheimer cut shares of Transcat from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 29th. Finally, StockNews.com raised shares of Transcat from a “sell” rating to a “hold” rating in a research note on Tuesday, January 28th. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, Transcat presently has an average rating of “Hold” and a consensus price target of $111.50.

Institutional Trading of Transcat

Large investors have recently added to or reduced their stakes in the company. nVerses Capital LLC purchased a new position in shares of Transcat during the third quarter valued at $60,000. US Bancorp DE increased its holdings in shares of Transcat by 15.6% in the 3rd quarter. US Bancorp DE now owns 1,547 shares of the scientific and technical instruments company’s stock valued at $187,000 after purchasing an additional 209 shares during the period. Captrust Financial Advisors purchased a new stake in shares of Transcat in the third quarter worth approximately $201,000. SG Americas Securities LLC acquired a new stake in shares of Transcat during the fourth quarter worth approximately $182,000. Finally, Walleye Capital LLC purchased a new position in Transcat during the third quarter valued at approximately $216,000. 98.34% of the stock is owned by institutional investors and hedge funds.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.